{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:23:39Z","timestamp":1786987419253,"version":"build-2736575974"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["PO1 AI057788"],"award-info":[{"award-number":["PO1 AI057788"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Robert Welch Foundation","award":["Q1279"],"award-info":[{"award-number":["Q1279"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.coviro.2016.06.002","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T10:00:39Z","timestamp":1466244039000},"page":"117-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Antiviral targets of human noroviruses"],"prefix":"10.1016","volume":"18","author":[{"given":"BV Venkataram","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreejesh","family":"Shanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zana","family":"Muhaxhiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisheng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Mun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K","family":"Estes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongcheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Palzkill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L","family":"Atmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2016.06.002_bib0490","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MOG.0000000000000022","article-title":"Epidemiology of human noroviruses and updates on vaccine development","volume":"30","author":"Ramani","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0495","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3201\/eid1908.130465","article-title":"Norovirus disease in the United States","volume":"19","author":"Hall","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"Suppl. 5","key":"10.1016\/j.coviro.2016.06.002_bib0500","doi-asserted-by":"crossref","first-page":"S381","DOI":"10.1093\/cid\/cis257","article-title":"Foodborne Diseases Active Surveillance Network (FoodNet) in 2012: a foundation for food safety in the United States","volume":"54","author":"Scallan","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2016.06.002_bib0505","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMra1207742","article-title":"Norovirus gastroenteritis in immunocompromised patients","volume":"367","author":"Bok","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.06.002_bib0510","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1086\/605557","article-title":"Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity","volume":"49","author":"Roddie","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2016.06.002_bib0515","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jpids\/pis070","article-title":"Noroviruses: the most common pediatric viral enteric pathogen at a large university hospital after introduction of rotavirus vaccination","volume":"2","author":"Koo","year":"2013","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0520","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMsa1206589","article-title":"Norovirus and medically attended gastroenteritis in U.S. children","volume":"368","author":"Payne","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.06.002_bib0525","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1016\/j.vaccine.2012.09.040","article-title":"The potential economic value of a human norovirus vaccine for the United States","volume":"30","author":"Bartsch","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.06.002_bib0530","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3201\/eid1408.071114","article-title":"Systematic literature review of role of noroviruses in sporadic gastroenteritis","volume":"14","author":"Patel","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.coviro.2016.06.002_bib0535","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00705-013-1708-5","article-title":"Proposal for a unified norovirus nomenclature and genotyping","volume":"158","author":"Kroneman","year":"2013","journal-title":"Arch Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0540","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1128\/JCM.00499-08","article-title":"Analysis of integrated virological and epidemiological reports of norovirus outbreaks collected within the Foodborne Viruses in Europe network from 1 July 2001 to 30 June 2006","volume":"46","author":"Kroneman","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0545","doi-asserted-by":"crossref","first-page":"9932","DOI":"10.1128\/JVI.00674-07","article-title":"Epochal evolution of GGII.4 norovirus capsid proteins from 1995 to 2006","volume":"81","author":"Siebenga","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0550","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-065X.2008.00680.x","article-title":"Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations","volume":"225","author":"Donaldson","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coviro.2016.06.002_bib0555","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1586\/erv.12.145","article-title":"Norovirus virus-like particle vaccines for the prevention of acute gastroenteritis","volume":"12","author":"Richardson","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coviro.2016.06.002_bib0560","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/infdis\/jiu337","article-title":"A novel intramuscular bivalent norovirus virus-like particle vaccine candidate\u2014reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults","volume":"210","author":"Treanor","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.06.002_bib0565","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1586\/erv.12.78","article-title":"Norovirus vaccine development: next steps","volume":"11","author":"Atmar","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0570","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk Virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2016.06.002_bib0575","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1016\/j.vaccine.2012.03.050","article-title":"Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations","volume":"30","author":"Parra","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0580","doi-asserted-by":"crossref","first-page":"e1001807","DOI":"10.1371\/journal.pmed.1001807","article-title":"Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial","volume":"12","author":"Lindesmith","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.coviro.2016.06.002_bib0585","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.286.5438.287","article-title":"X-ray crystallographic structure of the Norwalk virus capsid","volume":"286","author":"Prasad","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.06.002_bib0590","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/JVI.66.11.6527-6532.1992","article-title":"Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein","volume":"66","author":"Jiang","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0595","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1128\/JVI.79.11.6714-6722.2005","article-title":"Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns","volume":"79","author":"Huang","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0600","doi-asserted-by":"crossref","first-page":"9728","DOI":"10.1128\/JVI.01249-14","article-title":"particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs","volume":"88","author":"Kocher","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0605","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2217\/fvl.15.57","article-title":"Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives","volume":"10","author":"Kocher","year":"2015","journal-title":"Future Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0610","doi-asserted-by":"crossref","first-page":"e63269","DOI":"10.1371\/journal.pone.0063269","article-title":"Norovirus P particle efficiently elicits innate, humoral and cellular immunity","volume":"8","author":"Fang","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2016.06.002_bib0615","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.antiviral.2014.02.012","article-title":"Treatment of norovirus infections: moving antivirals from the bench to the bedside","volume":"105","author":"Kaufman","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.coviro.2016.06.002_bib0620","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1517\/13543776.2016.1153065","article-title":"Anti-norovirus therapeutics: a patent review (2010\u20132015)","volume":"26","author":"Galasiti Kankanamalage","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.coviro.2016.06.002_bib0625","doi-asserted-by":"crossref","first-page":"9438","DOI":"10.1021\/acs.jmedchem.5b00762","article-title":"Recent advances in the discovery of norovirus therapeutics","volume":"58","author":"Kim","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.coviro.2016.06.002_bib0630","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1086\/339883","article-title":"Norwalk virus infection and disease is associated with ABO histo-blood group type","volume":"185","author":"Hutson","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.06.002_bib0635","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1053\/gast.2002.33661","article-title":"Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals","volume":"122","author":"Marionneau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2016.06.002_bib0640","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1128\/JVI.00135-08","article-title":"Structural basis for the receptor binding specificity of Norwalk virus","volume":"82","author":"Bu","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0645","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1128\/JVI.00219-07","article-title":"Structural basis for the recognition of blood group trisaccharides by norovirus","volume":"81","author":"Cao","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0650","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1073\/pnas.0803275105","article-title":"Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus","volume":"105","author":"Choi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.06.002_bib0655","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1128\/JVI.00246-11","article-title":"Crystal structures of GII.10 and GII.12 norovirus protruding domains in complex with histo-blood group antigens reveal details for a potential site of vulnerability","volume":"85","author":"Hansman","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0660","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1128\/JVI.00278-12","article-title":"Structural basis for the recognition of Lewis antigens by genogroup I norovirus","volume":"86","author":"Kubota","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0665","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1128\/JVI.00848-11","article-title":"Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution","volume":"85","author":"Shanker","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0670","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1128\/JVI.00201-14","article-title":"Structural analysis of determinants of histo-blood group antigen binding specificity in genogroup I noroviruses","volume":"88","author":"Shanker","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0675","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.coviro.2014.05.008","article-title":"Structural basis of glycan interaction in gastroenteric viral pathogens","volume":"7","author":"Prasad","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0680","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JVI.05909-11","article-title":"Structural basis for norovirus inhibition and fucose mimicry by citrate","volume":"86","author":"Hansman","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0685","doi-asserted-by":"crossref","first-page":"48433","DOI":"10.1128\/JVI.03223-15","article-title":"Structural basis for norovirus inhibition by human milk oligosaccharides","volume":"90","author":"Weichert","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0690","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.1014577107","article-title":"Chimpanzees as an animal model for human norovirus infection and vaccine development","volume":"108","author":"Bok","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.06.002_bib0695","article-title":"Development and maturation of norovirus antibodies in childhood","author":"Blazevic","year":"2015","journal-title":"Microbes Infect"},{"key":"10.1016\/j.coviro.2016.06.002_bib0700","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.06200-11","article-title":"Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002","volume":"86","author":"Lindesmith","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0705","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/CVI.05592-11","article-title":"Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus","volume":"19","author":"Czako","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0710","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0715","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/CVI.00516-14","article-title":"Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity","volume":"22","author":"Czako","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0720","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.vaccine.2013.01.025","article-title":"Monoclonal antibodies for prophylactic and therapeutic use against viral infections","volume":"31","author":"Both","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2016.06.002_bib0725","doi-asserted-by":"crossref","first-page":"12335","DOI":"10.1128\/JVI.76.23.12335-12343.2002","article-title":"Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice","volume":"76","author":"Harrington","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0730","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/JVI.02179-09","article-title":"Heterotypic humoral and cellular immune responses following Norwalk virus infection","volume":"84","author":"Lindesmith","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0735","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrmicro2296","article-title":"Viral shape-shifting: norovirus evasion of the human immune system","volume":"8","author":"Donaldson","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0740","doi-asserted-by":"crossref","first-page":"ofv084","DOI":"10.1093\/ofid\/ofv084","article-title":"Serum immunoglobulin A cross-strain blockade of human noroviruses","volume":"2","author":"Lindesmith","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0745","doi-asserted-by":"crossref","first-page":"e0133665","DOI":"10.1371\/journal.pone.0133665","article-title":"Llama nanoantibodies with therapeutic potential against human norovirus diarrhea","volume":"10","author":"Garaicoechea","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2016.06.002_bib0750","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1099\/vir.0.059634-0","article-title":"Norovirus gene expression and replication","volume":"95","author":"Thorne","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0755","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1743-422X-9-181","article-title":"Secretory pathway antagonism by calicivirus homologues of Norwalk virus nonstructural protein p22 is restricted to noroviruses","volume":"9","author":"Sharp","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.coviro.2016.06.002_bib0760","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/JVI.75.4.1611-1619.2001","article-title":"Polypeptide p41 of a Norwalk-like virus is a nucleic acid-independent nucleoside triphosphatase","volume":"75","author":"Pfister","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0765","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1128\/JVI.76.14.7060-7072.2002","article-title":"Processing map and essential cleavage sites of the nonstructural polyprotein encoded by ORF1 of the feline calicivirus genome","volume":"76","author":"Sosnovtsev","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.femsle.2005.08.031","article-title":"Norovirus protein structure and function","volume":"253","author":"Hardy","year":"2005","journal-title":"FEMS Microbiol Lett"},{"issue":"Suppl. 2","key":"10.1016\/j.coviro.2016.06.002_bib0775","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1086\/315575","article-title":"Organization and expression of calicivirus genes","volume":"181","author":"Clarke","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2016.06.002_bib0780","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0042-6822(03)00004-7","article-title":"Processing of Norwalk virus nonstructural proteins by a 3C-like cysteine proteinase","volume":"308","author":"Blakeney","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2016.06.002_bib0785","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0168-1702(02)00114-4","article-title":"Substrate specificity of the Norwalk virus 3C-like proteinase","volume":"89","author":"Hardy","year":"2002","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2016.06.002_bib0790","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2005.02.002","article-title":"Characterization of the norovirus 3C-like protease","volume":"110","author":"Someya","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0795","doi-asserted-by":"crossref","DOI":"10.1039\/c3md00219e","article-title":"Synthesis, activity and structure\u2013activity relationship of noroviral protease inhibitors","volume":"4","author":"Deng","year":"2013","journal-title":"MedChemComm"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0800","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1016\/j.bmcl.2011.07.016","article-title":"Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C protease","volume":"21","author":"Tiew","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0805","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1016\/j.bmcl.2013.05.021","article-title":"Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus","volume":"23","author":"Mandadapu","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.coviro.2016.06.002_bib0810","doi-asserted-by":"crossref","first-page":"6487","DOI":"10.1128\/JVI.68.10.6487-6495.1994","article-title":"Identification and characterization of a 3C-like protease from rabbit hemorrhagic disease virus, a calicivirus","volume":"68","author":"Boniotti","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0815","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1128\/JVI.80.10.5050-5058.2006","article-title":"X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution","volume":"80","author":"Zeitler","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0820","doi-asserted-by":"crossref","first-page":"7872","DOI":"10.1073\/pnas.85.21.7872","article-title":"Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications","volume":"85","author":"Bazan","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.06.002_bib0825","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1021\/bi1008497","article-title":"A structural study of norovirus 3C protease specificity: binding of a designed active site-directed peptide inhibitor","volume":"50","author":"Hussey","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.coviro.2016.06.002_bib0830","doi-asserted-by":"crossref","first-page":"13685","DOI":"10.1128\/JVI.79.21.13685-13693.2005","article-title":"A norovirus protease structure provides insights into active and substrate binding site integrity","volume":"79","author":"Nakamura","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0835","doi-asserted-by":"crossref","first-page":"e38723","DOI":"10.1371\/journal.pone.0038723","article-title":"Structure of a murine norovirus NS6 protease-product complex revealed by adventitious crystallisation","volume":"7","author":"Leen","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.coviro.2016.06.002_bib0840","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1128\/JVI.03151-12","article-title":"Structures of the compact helical core domains of feline calicivirus and murine norovirus VPg proteins","volume":"87","author":"Leen","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0845","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1128\/JVI.02869-12","article-title":"Structural basis of substrate specificity and protease inhibition in Norwalk virus","volume":"87","author":"Muhaxhiri","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0850","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejmech.2016.04.013","article-title":"Structure-based design and synthesis of triazole-based macrocyclic inhibitors of norovirus protease: structural, biochemical, spectroscopic, and antiviral studies","volume":"119","author":"Weerawarna","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.coviro.2016.06.002_bib0855","doi-asserted-by":"crossref","first-page":"10312","DOI":"10.1128\/JVI.01111-14","article-title":"Development of a Gaussia luciferase-based human norovirus protease reporter system: cell type-specific profile of Norwalk virus protease precursors and evaluation of inhibitors","volume":"88","author":"Qu","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0860","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.virol.2006.06.006","article-title":"Stable expression of a Norwalk virus RNA replicon in a human hepatoma cell line","volume":"353","author":"Chang","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2016.06.002_bib0865","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1021\/jm5019934","article-title":"Structure-guided design and optimization of dipeptidyl inhibitors of norovirus 3CL protease. Structure\u2013activity relationships and biochemical, X-ray crystallographic, cell-based, and in vivo studies","volume":"58","author":"Galasiti Kankanamalage","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.coviro.2016.06.002_bib0870","doi-asserted-by":"crossref","first-page":"11754","DOI":"10.1128\/JVI.01348-12","article-title":"Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses","volume":"86","author":"Kim","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0875","doi-asserted-by":"crossref","first-page":"16638","DOI":"10.1074\/jbc.M400584200","article-title":"Crystal structure of Norwalk virus polymerase reveals the carboxyl terminus in the active site cleft","volume":"279","author":"Ng","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2016.06.002_bib0880","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.1074\/jbc.M709563200","article-title":"Structural insights into mechanisms of catalysis and inhibition in Norwalk virus polymerase","volume":"283","author":"Zamyatkin","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2016.06.002_bib0885","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1128\/JVI.01462-06","article-title":"Structural and functional characterization of sapovirus RNA-dependent RNA polymerase","volume":"81","author":"Fullerton","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0890","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1099\/vir.0.031104-0","article-title":"Crystal structures of murine norovirus-1 RNA-dependent RNA polymerase","volume":"92","author":"Lee","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0895","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1099\/vir.0.005629-0","article-title":"The active form of the norovirus RNA-dependent RNA polymerase is a homodimer with cooperative activity","volume":"90","author":"Hogbom","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0900","first-page":"137","article-title":"Structure\u2013function relationships among RNA-dependent RNA polymerases","volume":"320","author":"Ng","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0905","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1074\/jbc.M109261200","article-title":"Crystal structures of active and inactive conformations of a caliciviral RNA-dependent RNA polymerase","volume":"277","author":"Ng","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2016.06.002_bib0910","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jmb.2012.03.008","article-title":"Structure-based inhibition of Norovirus RNA-dependent RNA polymerases","volume":"419","author":"Mastrangelo","year":"2012","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0915","doi-asserted-by":"crossref","first-page":"e91765","DOI":"10.1371\/journal.pone.0091765","article-title":"Structural bases of norovirus RNA dependent RNA polymerase inhibition by novel suramin-related compounds","volume":"9","author":"Croci","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0920","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bbrc.2012.10.003","article-title":"Inhibition of norovirus replication by the nucleoside analogue 2\u2032-C-methylcytidine","volume":"427","author":"Rocha-Pereira","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coviro.2016.06.002_bib0925","doi-asserted-by":"crossref","first-page":"12111","DOI":"10.1128\/JVI.00560-07","article-title":"Interferons and ribavirin effectively inhibit Norwalk virus replication in replicon-bearing cells","volume":"81","author":"Chang","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0930","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3851\/IMP2229","article-title":"Antiviral activity of nucleoside analogues against norovirus","volume":"17","author":"Costantini","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.coviro.2016.06.002_bib0935","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1128\/AAC.01391-15","article-title":"Biochemical evaluation of the inhibition properties of favipiravir and 2\u2032-C-methyl-cytidine triphosphates against human and mouse norovirus RNA polymerases","volume":"59","author":"Jin","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2016.06.002_bib0940","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1128\/AAC.02799-13","article-title":"Nonnucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design","volume":"58","author":"Eltahla","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coviro.2016.06.002_bib0945","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1128\/JVI.00231-09","article-title":"Type I and type II interferons inhibit the translation of murine norovirus proteins","volume":"83","author":"Changotra","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0950","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1258100","article-title":"Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity","volume":"347","author":"Nice","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0955","doi-asserted-by":"crossref","first-page":"11977","DOI":"10.1128\/JVI.00432-12","article-title":"Identification of RNA-protein interaction networks involved in the norovirus life cycle","volume":"86","author":"Vashist","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2016.06.002_bib0960","doi-asserted-by":"crossref","first-page":"e94491","DOI":"10.1371\/journal.pone.0094491","article-title":"Chemical derivatives of a small molecule deubiquitinase inhibitor have antiviral activity against several RNA viruses","volume":"9","author":"Gonzalez-Hernandez","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0965","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1073\/pnas.1415096111","article-title":"Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA","volume":"111","author":"Katayama","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coviro.2016.06.002_sbref0970","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1126\/science.1257147","article-title":"Enteric bacteria promote human and mouse norovirus infection of B cells","volume":"346","author":"Jones","year":"2014","journal-title":"Science"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716300645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625716300645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T10:30:07Z","timestamp":1600770607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625716300645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":97,"alternative-id":["S1879625716300645"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2016.06.002","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726442870.793527513","asserted-by":"object"}]},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiviral targets of human noroviruses","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2016.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}